Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,445 | -5,401 | -20,840 | -15,475 | -10,214 |
| Depreciation Amortization | -194 | -106 | -771 | -567 | -331 |
| Other Working Capital | -2,462 | -2,074 | -462 | -1,489 | -3,096 |
| Other Operating Activity | 791 | 554 | 2,041 | 1,568 | 1,261 |
| Operating Cash Flow | $-12,310 | $-7,027 | $-20,032 | $-15,963 | $-12,380 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,249 | 6,536 | 10,102 | 15,816 | 3,564 |
| Net Acquisitions | -100 | -100 | N/A | N/A | N/A |
| Investing Cash Flow | $18,149 | $6,436 | $10,102 | $15,816 | $3,564 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32 | 0 | 476 | 452 | 452 |
| Other Financing Activity | -142 | -142 | -91 | -91 | -85 |
| Financing Cash Flow | $-110 | $-142 | $385 | $361 | $367 |
| Exchange Rate Effect | -29 | -55 | -16 | 60 | -15 |
| Beginning Cash Position | 22,593 | 22,593 | 32,154 | 32,154 | 32,154 |
| End Cash Position | 28,293 | 21,805 | 22,593 | 32,428 | 23,690 |
| Net Cash Flow | $5,700 | $-788 | $-9,561 | $274 | $-8,464 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,310 | -7,027 | -20,032 | -15,963 | -12,380 |
| Free Cash Flow | -12,310 | -7,027 | -20,032 | -15,963 | -12,380 |